In this issue:
Fistula injections of allogeneic human amnion epithelial cells for perianal CD
Ustekinumab vs. vedolizumab for anti-TNF-naïve or -exposed CD
Impact of changes in medical salvage of acute severe UC on colectomy rates
IBD in Waikato, New Zealand
Bowel urgency in IBD
MMES complements prediction of long-term clinical outcomes in UC
Curcumin-QingDai for active UC
E. coli Nissle reduces faecal calprotectin and UC flares
Switching from intravenous to subcutaneous vedolizumab in IBD
Childlessness in IBD
Please login below to download this issue (PDF)